How Wisp built telehealth for women that delivers same-day care, overcomes stigma, and remains profitable amid healthcare ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.

Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows treatment through age 65.

For the first time, postmenopausal women have an FDA-approved treatment for low desire. Eckert explains why that validation ...

GPNs are the ‘backbone’ of sexual and reproductive healthcare but are being held back by training gaps, workforce pressures ...

In 2025, cardiology delved deeper into sex-specific risk factors and how to leverage them in prevention, Stacey Rosen says.

In the last year or so, health influencers — and a lot of women on social media — have talked up testosterone therapy as a ...

A federal judge has approved a preliminary agreement for a class action lawsuit requiring Aetna to cover fertility treatments ...

This special report explores why affective disorders are more prevalent in women across the lifespan, highlighting the ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Former Colgate goalkeeper Amelia Cunningham sued the university in Manhattan, claiming the school was negligent and ...